You will find here brochures, surveys & studies, and other business-oriented documents published by Mazars.
A year like no other: Mazars publishes 2019/20 annual report
For people, businesses and society, 2020 was a year like no other. With the global Covid-19 crisis many have faced extreme challenges; people and families across the world have lost loved ones too early and suffered previously unthinkable restrictions to their lives and livelihoods as governments, companies and other institutions battled to contain the virus. The unique challenge for business has been how to respect the necessity to preserve life while fulfilling its duty to meet society’s needs in a financially sustainable way.
Transfer pricing and DAC 6 obligations for US multinationals in Romania
Transfer pricing (“TP”) has been a hot topic for the Romanian Tax Authorities (“RTA”) in the past 10 years. The number of TP audits has gradually increased during this period together with the amount of additional corporate tax assessed by RTA.
In 2020 and for the fifth year in a row, Mazars has been ranked among the top 5 leading deal advisors in Central & Eastern Europe, based on Mergermarket CEE Accountant League table by number of successful deals.
The future of audit: market view – myths, realities and ways forward
The audit profession faces a decisive moment: market expectations are shifting, technology is empowering auditors and strengthening quality, the case for audit’s evolution is growing and a series of headline corporate failures have raised questions about the quality of service companies can expect.
The M&A market in Central and Eastern Europe (CEE) had a robust 2019 year, displaying resilience in the face of global economic headwinds, according to new research from Mazars in association with Mergermarket. The report, Investing in CEE: Inbound M&A Report 2019/2020, offers an overview of inbound M&A activity in the CEE region throughout 2019 and looks ahead to the opportunities and challenges in the coming months, notably in the context of the ongoing Covid-19 outbreak.